RIC versus MAC UCBT in adults with AML
Nonrelapse mortality (NRM) is the first cause of treatment failure after unrelated cord blood transplantation (UCBT) following myeloablative conditioning (MAC). In the last decade, reduced-intensity conditioning (RIC) regimens have been developed with the aim of reducing NRM and allowing older patie...
| Autores: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2016 |
| País: | España |
| Institución: | Universitat Autònoma de Barcelona |
| Repositorio: | Dipòsit Digital de Documents de la UAB |
| Idioma: | inglés |
| OAI Identifier: | oai:ddd.uab.cat:289627 |
| Acceso en línea: | https://ddd.uab.cat/record/289627 https://dx.doi.org/urn:doi:10.18632/oncotarget.9599 |
| Access Level: | acceso abierto |
| Palabra clave: | AML Myeloablative Reduced-intensity Transplantation Unrelated cord blood |
| id |
ES_99da4c74a3eb4e7c5e130db88a6377e7 |
|---|---|
| oai_identifier_str |
oai:ddd.uab.cat:289627 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
RIC versus MAC UCBT in adults with AMLA report from Eurocord, the ALWP and the CTIWP of the EBMTBaron, Frederic|||0000-0002-2944-3812Ruggeri, Annalisa|||0000-0002-7261-2765Beohou, EricLabopin, Myriam|||0000-0003-4514-4748Sanz, Guillermo|||0000-0002-2767-8191Milpied, Noel|||0000-0002-5177-014XMichallet, MauricetteBacigalupo, AndreaBlaise, Didier|||0000-0002-5684-9447Malouf Sierra, Jorge|||0000-0001-5185-520XSocié, Gérard|||0000-0002-2114-7533Cornelissen, Jan J.Schmid, ChristophGiebel, SebastianGorin, Norbert-ClaudeEsteve Reyner, Jordi|||0000-0002-8056-648XCiceri, Fabio|||0000-0003-0873-0123Savani, Bipin|||0000-0002-3304-9965Mohty, Mohamad|||0000-0002-7264-808XGluckman, ElianeNagler, ArnonAMLMyeloablativeReduced-intensityTransplantationUnrelated cord bloodNonrelapse mortality (NRM) is the first cause of treatment failure after unrelated cord blood transplantation (UCBT) following myeloablative conditioning (MAC). In the last decade, reduced-intensity conditioning (RIC) regimens have been developed with the aim of reducing NRM and allowing older patients and those with medical comorbidities to benefit from UCBT. The aim of the current retrospective study was to compare transplantation outcomes of acute myeloid leukemia (AML) patients given UCBT after either RIC or MAC. Data from 894 adults with AML receiving a single or double UCBT as first allograft from 2004 to 2013 at EBMT centers were included in this study. 415 patients were given UCBT after RIC while 479 patients following a MAC. In comparison to MAC recipients, RIC recipients had a similar incidence of neutrophil engraftment and of acute and chronic graft-versus-host disease (GVHD). However, RIC recipients had a higher incidence of disease relapse and a lower NRM, translating to comparable leukemia-free (LFS), GVHD-free, relapse-free survival (GRFS) and overall survival (OS). These observations remained qualitatively similar after adjusting for differences between groups in multivariate analyses. In conclusion, these data suggest that LFS and OS are similar with RIC or with MAC in adults AML patients transplanted with UCBT. These observations could serve as basis for a future prospective randomized study.Universitat Autònoma de Barcelona 22016-01-0120162016-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/289627https://dx.doi.org/urn:doi:10.18632/oncotarget.9599reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:2896272026-06-06T12:50:31Z |
| dc.title.none.fl_str_mv |
RIC versus MAC UCBT in adults with AML A report from Eurocord, the ALWP and the CTIWP of the EBMT |
| title |
RIC versus MAC UCBT in adults with AML |
| spellingShingle |
RIC versus MAC UCBT in adults with AML Baron, Frederic|||0000-0002-2944-3812 AML Myeloablative Reduced-intensity Transplantation Unrelated cord blood |
| title_short |
RIC versus MAC UCBT in adults with AML |
| title_full |
RIC versus MAC UCBT in adults with AML |
| title_fullStr |
RIC versus MAC UCBT in adults with AML |
| title_full_unstemmed |
RIC versus MAC UCBT in adults with AML |
| title_sort |
RIC versus MAC UCBT in adults with AML |
| dc.creator.none.fl_str_mv |
Baron, Frederic|||0000-0002-2944-3812 Ruggeri, Annalisa|||0000-0002-7261-2765 Beohou, Eric Labopin, Myriam|||0000-0003-4514-4748 Sanz, Guillermo|||0000-0002-2767-8191 Milpied, Noel|||0000-0002-5177-014X Michallet, Mauricette Bacigalupo, Andrea Blaise, Didier|||0000-0002-5684-9447 Malouf Sierra, Jorge|||0000-0001-5185-520X Socié, Gérard|||0000-0002-2114-7533 Cornelissen, Jan J. Schmid, Christoph Giebel, Sebastian Gorin, Norbert-Claude Esteve Reyner, Jordi|||0000-0002-8056-648X Ciceri, Fabio|||0000-0003-0873-0123 Savani, Bipin|||0000-0002-3304-9965 Mohty, Mohamad|||0000-0002-7264-808X Gluckman, Eliane Nagler, Arnon |
| author |
Baron, Frederic|||0000-0002-2944-3812 |
| author_facet |
Baron, Frederic|||0000-0002-2944-3812 Ruggeri, Annalisa|||0000-0002-7261-2765 Beohou, Eric Labopin, Myriam|||0000-0003-4514-4748 Sanz, Guillermo|||0000-0002-2767-8191 Milpied, Noel|||0000-0002-5177-014X Michallet, Mauricette Bacigalupo, Andrea Blaise, Didier|||0000-0002-5684-9447 Malouf Sierra, Jorge|||0000-0001-5185-520X Socié, Gérard|||0000-0002-2114-7533 Cornelissen, Jan J. Schmid, Christoph Giebel, Sebastian Gorin, Norbert-Claude Esteve Reyner, Jordi|||0000-0002-8056-648X Ciceri, Fabio|||0000-0003-0873-0123 Savani, Bipin|||0000-0002-3304-9965 Mohty, Mohamad|||0000-0002-7264-808X Gluckman, Eliane Nagler, Arnon |
| author_role |
author |
| author2 |
Ruggeri, Annalisa|||0000-0002-7261-2765 Beohou, Eric Labopin, Myriam|||0000-0003-4514-4748 Sanz, Guillermo|||0000-0002-2767-8191 Milpied, Noel|||0000-0002-5177-014X Michallet, Mauricette Bacigalupo, Andrea Blaise, Didier|||0000-0002-5684-9447 Malouf Sierra, Jorge|||0000-0001-5185-520X Socié, Gérard|||0000-0002-2114-7533 Cornelissen, Jan J. Schmid, Christoph Giebel, Sebastian Gorin, Norbert-Claude Esteve Reyner, Jordi|||0000-0002-8056-648X Ciceri, Fabio|||0000-0003-0873-0123 Savani, Bipin|||0000-0002-3304-9965 Mohty, Mohamad|||0000-0002-7264-808X Gluckman, Eliane Nagler, Arnon |
| author2_role |
author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Universitat Autònoma de Barcelona |
| dc.subject.none.fl_str_mv |
AML Myeloablative Reduced-intensity Transplantation Unrelated cord blood |
| topic |
AML Myeloablative Reduced-intensity Transplantation Unrelated cord blood |
| description |
Nonrelapse mortality (NRM) is the first cause of treatment failure after unrelated cord blood transplantation (UCBT) following myeloablative conditioning (MAC). In the last decade, reduced-intensity conditioning (RIC) regimens have been developed with the aim of reducing NRM and allowing older patients and those with medical comorbidities to benefit from UCBT. The aim of the current retrospective study was to compare transplantation outcomes of acute myeloid leukemia (AML) patients given UCBT after either RIC or MAC. Data from 894 adults with AML receiving a single or double UCBT as first allograft from 2004 to 2013 at EBMT centers were included in this study. 415 patients were given UCBT after RIC while 479 patients following a MAC. In comparison to MAC recipients, RIC recipients had a similar incidence of neutrophil engraftment and of acute and chronic graft-versus-host disease (GVHD). However, RIC recipients had a higher incidence of disease relapse and a lower NRM, translating to comparable leukemia-free (LFS), GVHD-free, relapse-free survival (GRFS) and overall survival (OS). These observations remained qualitatively similar after adjusting for differences between groups in multivariate analyses. In conclusion, these data suggest that LFS and OS are similar with RIC or with MAC in adults AML patients transplanted with UCBT. These observations could serve as basis for a future prospective randomized study. |
| publishDate |
2016 |
| dc.date.none.fl_str_mv |
2 2016-01-01 2016 2016-01-01 |
| dc.type.none.fl_str_mv |
Article http://purl.org/coar/resource_type/c_6501 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://ddd.uab.cat/record/289627 https://dx.doi.org/urn:doi:10.18632/oncotarget.9599 |
| url |
https://ddd.uab.cat/record/289627 https://dx.doi.org/urn:doi:10.18632/oncotarget.9599 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.source.none.fl_str_mv |
reponame:Dipòsit Digital de Documents de la UAB instname:Universitat Autònoma de Barcelona |
| instname_str |
Universitat Autònoma de Barcelona |
| reponame_str |
Dipòsit Digital de Documents de la UAB |
| collection |
Dipòsit Digital de Documents de la UAB |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869414323170836480 |
| score |
15.300719 |